Clinical Trials Browser

Phase 2 × Withdrawn × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT03173859 2020-11-18

AERA

Phase 2 Withdrawn

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT02906605 2016-11-22

A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms, Castration-Resistant